FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pharmacology, pathophysiology and physiology. Substance of invention is use of peptide Gly-His-Lys-Gly-Pro to achieve anxiolytic effect.
EFFECT: invention enables to achieve anxiolytic effect when using different doses of peptide Gly-His-Lys-Gly-Pro.
1 cl, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICATION, POSSESSING ANXIOLYTIC ACTIVITY | 2013 |
|
RU2519191C1 |
| USE OF PEPTIDE Gly-His-Lys-Pro-Gly-Pro TO ACHIEVE ANALGESIC EFFECT IN PAIN CAUSED BY TEMPERATURE IRRITATION | 2018 |
|
RU2687740C1 |
| AGENT POSSESSING ANXIOLYTHIC ACTION, ON BASIS OF HYDROGENATED PYRIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND WAY OF ITS APPLICATION | 2007 |
|
RU2338533C1 |
| Use of Gly-His-Lys-Val-Glu-Pro peptide to improve learning abilty and memory. | 2020 |
|
RU2743293C1 |
| USE OF PEPTIDE Gly-His-Lys FOR ANXIOLYTIC EFFECT | 2012 |
|
RU2480232C1 |
| USE OF THE PEPTIDE GLY-HIS-LYS-PRO-GLY-PRO TO ACHIEVE AN ANTIDEPRESSANT EFFECT | 2020 |
|
RU2747224C1 |
| ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
| PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
| 2-ETHYL-6-METHYL-3-OXYPYRODINE SALTS WITH ORGANIC CARBOXYLIC ACIDS POSSESSING ANXIOLYTIC, ANTIDEPRESSIVE, ANTIHYPOXIC, ANTI-AMNESTIC AND ANTI-OXIDATIVE ACTIVITY AND METHOD FOR THEIR PREPARING | 2002 |
|
RU2284993C2 |
| NOVEL GLYPROLINS WITH NOOTROPIC, ANTI-HYPOXIC, NEUROPROTECTIVE AND ANSSIYLITIS ACTIVITY | 2016 |
|
RU2646604C2 |
